Insys Therapeutics (INSY) Stock Decreases -14.5% This Month: What’s Next?

 

nsys Therapeutics Inc (INSY) stock is down -14.5% over the last 30 days and has fallen -39.71% over the last 12 months. The average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives INSY stock a score of 40 out of a possible 100.

That score is primarily influenced by a long-term technical score of 14. INSY’s score also includes a fundamental score of 52. In addition to the average rating from Wall Street analysts, INSY stock has a mean target price of $7.60. This means analysts expect the stock to increase 84.02% over the next 12 months. The short-term technical score for INSY is 54.

Click Here to get the full Stock Score Report on Insys Therapeutics Inc (INSY).

What’s Happening with INSY Stock Today

Insys Therapeutics Inc (INSY) stock is down -3.5% while the S&P 500 has fallen -0.02% as of 10:40 AM on Wednesday, May 8. INSY has fallen -$0.15 from the previous closing price of $4.28 on volume of 43,377 shares. Over the past year the S&P 500 is higher by 7.89% while INSY has fallen -39.71%. INSY lost -$1.68 per share in the over the last 12 months.

Symbols: INSY

You May Also Like